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Inhibition of Allergic Inflammation
in a Murine Model of Asthma by Expression
of a Dominant-Negative Mutant of GATA-3
(Robinson et al., 1992; Maggi and Romagnani, 1994;
Gleich and Kita, 1997; Umetsu and DeKruyff, 1997).
The effector functions of Th2 cells are mediated by
the cytokines they secreteÐIL-4, IL-5, and IL-13. Recent
work utilizing mice with specific genetic deficiencies
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entiating cytokine (Kopf et al., 1993; Seder and Paul,System
1994; Morel and Oriss, 1998). The Th2 cells, in turn,West Haven, Connecticut 06516
produce more IL-4 together with IL-5 and IL-13. Using
IL-4Ra2/2 mice, we have recently shown that airway
mucus production is critically dependent on the IL-4RaSummary
chain but not on IL-4 or IL-5 (Cohn et al., 1999a). A
specific inhibitor of IL-13 was recently shown to causeThe cytokines IL-4, IL-5, and IL-13, secreted by Th2
severe inhibition of mucus production and AHR in acells, have distinct functions in the pathogenesis of
murine model of asthma, substantiating our studies inasthma. We have previously shown that the transcrip-
IL-4Ra2/2 mice (Grunig et al., 1998; Wills-Karp et al.,tion factor GATA-3 is expressed in Th2 but not Th1
1998). Use of the IL-13 inhibitor, however, did not reducecells. However, it was unclear whether GATA-3 con-
airway eosinophilia in antigen-challenged animals (Wills-trols the expression of all Th2 cytokines. Expression
Karp et al., 1998). The cytokine that is most intimatelyof a dominant-negative mutant of GATA-3 in mice in
associated with eosinophil biology is IL-5 (Coffman eta T cell±specific fashion led to a reduction in the levels
al., 1989; Dent et al., 1990; Foster et al., 1996; Kopf etof all the Th2 cytokines IL-4, IL-5, and IL-13. Airway
al., 1996; Cohn et al., 1999a). It not only regulates theeosinophilia, mucus production, and IgE synthesis, all
proliferation, differentiation, and activation of eosino-key features of asthma, were severely attenuated in
phils, it also provides an essential signal for the rapidthe transgenic mice. Thus, targeting GATA-3 activity
mobilization of eosinophils from the bone marrow andalone is sufficient to blunt Th2 responses in vivo,
cooperates with chemokines such as eotaxin in thethereby establishing GATA-3 as a potential therapeutic
homing of eosinophils to sites of allergic inflammationtarget in the treatment of asthma and allergic dis-
(Lopez et al., 1988; Yamaguchi et al., 1990; Collins eteases.
al., 1995). Thus, IL-4, IL-5, and IL-13 all have distinct
roles in the pathogenesis of asthma.
Introduction
We and others have previously shown that the tran-
scription factor GATA-3 is expressed in a Th2-specific
Asthma is a debilitating disease of the lower airways fashion (Zhang et al., 1997; Zheng and Flavell, 1997). We
that affects millions of people worldwide. Both the prev- showed that GATA-3 mRNA expression is substantially
alence and severity of asthma is increasing at an increased at 48 hr during Th2 development and plateaus
alarming rate in developed countries, including the thereafter (Zhang et al., 1997). In contrast, no such in-
United States. Bronchoalveolar lavage (BAL) and biopsy crease is seen in developing Th1 cells, and there is
of patients with mild to moderate asthma has provided actually a progressive decline in GATA-3 mRNA expres-
impressive evidence for complex airway inflammation sion in developing Th1 cells (Zhang et al., 1997). In a
in asthma (Holgate, 1997; Busse, 1998; Gleich et al., recent study, forced expression of GATA-3 in developing
1988). The hallmarks of allergic asthma are infiltration of Th1 cells caused abrogation of IL-12Rb2 subunit expres-
eosinophils into the bronchial wall and lumen, elevated sion and IFNg production (Ouyang et al., 1998). We and
serum IgE levels, mucus production in the airways, and others have shown that GATA-3 directly activates the
airway hyperresponsiveness (AHR) to specific and non- IL-5 promoter (Siegel et al., 1995; Zhang et al., 1997;
specific stimuli (Holgate, 1997; Busse, 1998; Gleich et Lee et al., 1998) and is critical and sufficient for IL-5
al., 1988; Wills-Karp, 1999). The most striking and con- gene expression in a non-Th2 environment (Zhang et
sistent pathophysiology in asthma is damage to the al., 1997; Zhang et al., 1998). In recent studies, we have
bronchial epithelium caused by the cytotoxic proteins demonstrated a significant increase in GATA-3 mRNA
released by the infiltrated eosinophils (de Monchy et al., expression in asthmatic airways compared to those of
1985; Gleich et al., 1988; Frick et al., 1989). Studies of control subjects (Nakamura et al., 1999). The increase
human asthma as well as of animal models of allergic in GATA-3 expression correlated significantly with IL-5
inflammation/asthma highlight a critical role for CD41 expression and AHR in the asthmatics (Nakamura et al.,
T helper 2 (Th2) cells as orchestrators of this disease 1999).
A previous report suggested that GATA-3 is sufficient
for IL-4 gene expression but has a minimal effect on IL-5§ To whom correspondence should be addressed (e-mail: anuradha.
ray@yale.edu). or IL-13 gene expression (Zheng and Flavell, 1997). In
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contrast, we (Zhang et al., 1998) and others (Ouyang et
al., 1998; Ranganath et al., 1998) have recently shown
that GATA-3 is not sufficient for optimal IL-4 gene ex-
pression in a non-Th2 environment. This suggests that
T cell factors such as c-Maf (Ho et al., 1996, 1998) (also
Th2-specific) and NF-ATc (Ranger et al., 1998; Yoshida
et al., 1998) together with GATA-3 might control optimal
IL-4 gene expression in Th2 cells (reviewed in Glimcher
and Singh, 1999). In addition, although GATA-3 is not
sufficient for IL-4 gene expression in either B cells
(Zhang et al., 1998) or in Th1 cells (Ouyang et al., 1998;
Ranganath et al., 1998), it is sufficient for IL-5 gene
expression in the same cells. There is as yet no evidence
that either c-Maf or NF-ATc is important for IL-5 or IL-13
gene expression. Intracellular cAMP-increasing agents
such as prostaglandins, which have been recognized
as important stimuli of Th2 responses (Phipps et al.,
1991), are potent inducers of IL-5 but not IL-4 gene
expression in effector T cells (Snijdewint et al., 1993).
We have recently shown that IL-5 but not IL-4 gene
expression is ablated in mice deficient in the p50 subunit
Figure 1. The Dominant-Negative Mutant of GATA-3, KRR, Bindsof NF-kB (Yang et al., 1998). Thus, it has been unclear
Weakly to the GATA-3 Doublet Present in the IL-5 Promoterwhether targeting GATA-3 activity alone in vivo would
(Upper panel) In vitro translated wild-type (WT) GATA-3 or mutantbe sufficient to inhibit the expression of the key Th2
(KRR) was obtained using the TNT wheat germ lysate system of
cytokine genes IL-4, IL-5 and IL-13 and, thus, the char- Promega. Equal volumes (0.5, 1, 2, and 6 ml) of the programmed
acteristic airway pathology in asthma. Since deficiency TNT lysates were allowed to interact with a double-stranded oligo-
of the GATA-3 gene causes embryonic lethality with nucleotide containing sequences between 273 and 254 containing
the double GATA site present in the IL-5 gene (273CCTCTATCTGATTsevere impairment of fetal liver hematopoiesis and brain
GTTAGCA254) as described previously (Siegel et al., 1995; Zhang etdevelopment (Pandolfi et al., 1995), we used an alternate
al., 1997). The anti-GATA-3 antibody was a mouse monoclonal IgG1approach to address our question. We generated trans-
that does not cross-react with GATA-1,-2, or 24 (Santa Cruz Bio-
genic mice expressing a dominant-negative mutant of technology) but recognizes both the WT and mutant GATA-3 pro-
GATA-3, in which amino acid residues KRR located be- teins. The anti-GATA-4 antibody was kindly provided by Dr. D. Wil-
tween 304 and 306 were altered to AAA (Smith et al son. The binding reactions were analyzed by electrophoresis on 6%
native poly acrylamide gels (acrylamide:bisacrylamide 5 30:1). Gels1995.; will be referred to as KRR hereafter). This mutant
were dried and subjected to autoradiography. Shown is a represen-was previously shown to inhibit GATA-3-dependent re-
tative experiment of two.porter gene activation (Smith et al., 1995). Our studies
(Lower panel) Western blot analysis of the TNT lysates. The sameshow that inhibition of GATA-3 activity attenuates asthma
volumes of the TNT lysates (2 ml) were resolved by SDS-PAGE and
pathogenesis in vivo. immunoblotting was performed with anti-GATA-3 antibody.
Results
the expression of KRR, similar to a system we previously
developed for transgene expression in an inducible andKRR Binds Weakly to a GATA Doublet
lung epithelial cell±specific fashion in mice (Ray et al.,Among all the Th2 cytokine genes, a functional GATA
1997). For inducible expression of the KRR gene in a Telement has been identified only in the IL-5 gene (Siegel
cell±specific fashion, the reverse tetracycline transacti-et al., 1995). We previously described the presence of
vator (rtTA) was expressed under the control of the Ta double GATA site in the IL-5 promoter located between
cell±specific lck proximal promoter/CD2 locus control270 and 260 that bound GATA-3 and was critical for
region (LCR) (Allen et al., 1992), which permits expres-activation of the promoter by multiple stimuli including
sion of a linked transgene in both thymic and peripheralantigen and cAMP (Siegel et al., 1995; Zhang et al.,
T cells (Figure 2A) (Perez et al., 1995; Youn et al., 1998).1997). We have further shown that both GATA elements
The KRR cDNA was inserted in a second plasmid down-in the GATA doublet are important for IL-5 promoter
stream of a tet operator/promoter (O/P) and a cytomega-activation (Zhang et al., 1998). Therefore, we first exam-
lovirus (CMV) minimal promoter. Human growth hor-ined the DNA-binding ability of KRR to the IL-5 double-
mone intronic and polyadenylation sequences wereGATA site. As shown in Figure 1, compared to wild-type
ligated to the 39 end of both cDNAs for stable expressionGATA-3, an equivalent amount of KRR bound weakly to
of the linked genes. We first tested the tet system andthe IL-5 GATA doublet. Thus, although KRR binds with
KRR function in vitro in Th2 cells. Th2 (D10) cells werean affinity similar to the wild-type protein to single GATA
transfected with an IL-5 promoter-reporter constructelements (Smith et al., 1995), its binding to GATA dou-
containing 1.7 kb of the IL-5 promoter together withblets, which are preferred binding sites for GATA pro-
the tet O/P-KRR plasmid with or without the lck-rtTAteins (Ko and Engel, 1993), is impaired.
plasmid, and the cells were treated with dox. As shown
in Figure 2B, antigen-induced IL-5 promoter activity wasGeneration of KRR Transgenic Mice
inhibited by 50%±60% when KRR expression was in-We used the tetracycline (tet)-inducible expression sys-
tem (Gossen and Bujard, 1992; Gossen et al., 1995) for duced by rtTA. The partial inhibition of IL-5 promoter
GATA-3 Is Critical for Asthma Pathogenesis
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Figure 2. Generation of KRR Mice
(A) Schemtaic diagram of constructs used for T cell±specific, inducible expression of KRR. The 309 bp template that was used to determine
KRR mRNA expression by RPA is shown.
(B) Inhibition of antigen-induced IL-5 promoter activation by KRR. Rested D10 cells were first stimulated with the antigen conalbumin and
mitomycin C±treated and T cell±depleted APCs in complete medium containing 5 U/ml IL-2 for 72 hr and then subjected to electroporation
as described previously. After 18±20 hr, cells were harvested and luciferase and b-galactosidase assays were performed. The fold activation
of the promoter by antigen is shown with results representing the average of three experiments and normalized for b-galactosidase activity.
The deviations were ,15% between experiments. The average absolute luciferase activity in samples without KRR expression was 3000
relative light units.
(C) Expression of KRR RNA and protein in nontransgenic (NTg) and transgenic (Tg) mice in the presence or absence of dox (1 mg/ml in
drinking water). Four days after dox induction, different organs of the animals including thymus (shown), spleen, and liver were harvested.
RNA was extracted from the organs for determination of transgene RNA expression by RNase protection analysis (RPA). To determine protein
expression (arrow), whole cell extracts were prepared from thymus (shown) or spleen and subjected to a sequential immunoprecipitation
(i.p.)-Western blot analysis using the murine anti-GATA-3 antibody (Santa Cruz Biotechnology). Note that in the absence of dox, the protein
expressed was predominantly the WT protein, which was equivalent in the NTg and Tg mice. In the presence of dox, KRR expression was
induced only in the Tg animals, which accounts for the net increase in protein expression in these animals. The faint band migrating above
the GATA-3 band and also seen in some of the control lanes is the immunoglobulin heavy chain partly released from the beads during boiling
in SDS buffer.
activation by KRR was likely due to the high basal ex- but not in the fetal thymus affected T cell development
(Hattori et al., 1996). All studies were carried out withpression of GATA-3 in D10 cells.
We next used the plasmid constructs encoding rtTA animals that were treated with dox to induce high level
expression of KRR in the T cells of the mice.and KRR to generate transgenic mice. We obtained five
transgenic lines, out of which three lines displayed rela-
tively high levels of transgene expression upon dox in- Inhibition of Th2 Cytokine Gene Expression and
Eosinophil Infiltration in the Lungs of KRR Miceduction in both the thymus (Figure 2C) and the spleen.
No expression was detected in the liver or other organs To test the effect of inhibition of GATA-3 activity on Th2
cytokine gene expression in vivo, transgenic mice andthat are not enriched in T lymphocytes (data not shown).
We also confirmed expression of the transgene in puri- nontransgenic littermate controls were treated with dox
and sensitized and challenged with Ova by inhalationfied CD41 T cells isolated from the spleen. The ratio of
CD41 and CD81 T cells and expression of the differentia- (hereafter referred to as Ova/Ova). Twenty-four hours
after challenge with Ova, mice were anesthetized, bron-tion marker CD3 were normal in the transgenic mice
(data not shown). Thus, although there was a low level choalveolar lavage fluid (BALF) was recovered from the
animals, and cytokine levels were measured in BALF.leaky expression of KRR in the absence of dox, this did
not impair T cell development in mice expressing the As shown in Figure 3A, the predominant cytokines pres-
ent in the BALF obtained from the control mice were ofGATA-3 mutant. This was consistent with previous stud-
ies in which inhibition of GATA-3 activity in the fetal liver the Th2-type, as was expected in this model. The levels
Immunity
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Figure 3. Decreased Cytokine Production and Leukocyte Infiltration in the Airways of KRR Mice
(A) Estimation of cytokines in BALF by ELISA. Mice were supplied with drinking water containing dox (1 mg/ml) for 4 days and then sensitized
and challenged with Ova. BAL was performed at 24 hr after aerosol challenge. Mice were anesthetized and the lungs and heart were surgically
exposed. The trachea were cannulated and the lungs were lavaged twice with 1 ml aliquots of PBS. The live cells (excluded trypan blue)
recovered were counted in a hemocytometer. Cytospin preparations of BAL cells were stained with Diff-Quik (Baxter HealthCare) and cell
differentials were enumerated based on morphology and staining profile. IL-4 levels, in general, were low in most mice, as has been previously
observed by us and other investigators (Alexander et al., 1998; Cohn et al., 1999).
(B) The total and differential cell counts in the BAL of wild-type and KRR mice are shown. Shown are mean 6 SEM (n 5 5 per group). Results
shown are representative of three experiments with three to five animals per group in each experiment.
(C) Similar proliferative responses of CD41 T cells isolated from WT and KRR mice. WT (closed symbols) and KRR (open symbols) mice were
treated with dox and sensitized with Ova plus alum on days 0 and 5, and on day 12 splenic T cells isolated from these mice were stimulated
in vitro with different concentrations of Ova (0.1±100 mg/ml) and mitomycin C±treated and T cell±depleted antigen-presenting cells (APC).
Aliquots of cells were pulsed with [3H]thymidine and incorporated counts were determined. Results shown are mean 6 SEM. Shown is a
representative experiment of two.
(D) WT and KRR mice (transgenic lines 1 and 4) were sensitized with Ova plus alum on days 0 and 5. On day 12, splenic CD41 T cells were
isolated, pooled from two to three mice in each group, and incubated with Ova, APC, IL-4, and anti-IFNg (Th2-skewing conditions) for 5 days.
Next, the cells were restimulated with Ova, APC, and IL-2 (10 U/ml) for 72 hr and culture supernatants were used for cytokine estimations by
ELISA.
of the Th2 cytokines IL-4, IL-5, and IL-13 present in the Similar Proliferative Responses but Differential
Cytokine Production by CD41 T CellsBALF of transgenic mice were lower than those recov-
ered from their nontransgenic littermates (Figure 3A). from Wild-Type and KRR Mice
We investigated whether the decrease in airway cyto-The inhibition of IL-5 and IL-13 production by KRR is
consistent with our previous results demonstrating the kine production in the KRR mice in response to antigen
challenge was due to a defect in the ability of CD41 Timportance of GATA-3 in IL-5 gene expression (Zhang
et al., 1997, 1998) and also with those of Ouyang et al. cells to respond to antigen. Wild-type and KRR mice
were immunized with Ova intraperitoneally and recall(1998), which show increased IL-5 and IL-13 expression
in GATA-3-expressing Th1 cells. The total cell count proliferative responses of spleen CD41 T cells were ana-
lyzed by [3H]thymidine incorporation. The CD41 T cellsin the BALF recovered from the transgenic mice upon
antigen challenge was 4- to 5-fold lower than that in the from the KRR mice proliferated as efficiently as the wild-
type cells in response to antigen, indicating that antigenBALF derived from the nontransgenic mice (Figure 3B).
After antigen provocation, while 60%±70% of the cells priming was intact in the transgenic animals (Figure 3C).
Cytokine production was measured in culture superna-present in the airways of the wild-type mice were eosino-
phils, only 5%±10% of the cells were eosinophils in the tants of the Ova-restimulated cells. As illustrated in Fig-
ure 3D, even when cytokine production was boosted byairways of the KRR mice (Figure 3B). Although the air-
way infiltration of other cells was also reduced in the prolonged incubation of the cultures in vitro under Th2-
differentiating conditions, the production of all three cy-transgenic mice, the most striking difference between
the transgenic and nontransgenic littermates was the tokines, IL-4, IL-5, and IL-13, was reduced to between
10% and 40% of the levels produced by the wild-typedifference in eosinophil numbers in the airways and lung
parenchyma (Figures 3B and 4). cells (Figure 3D). The residual cytokine expression in
GATA-3 Is Critical for Asthma Pathogenesis
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Figure 4. Inhibition of Airway Inflammation in
the Lungs of KRR Mice
(Upper panel) Lungs were prepared for histol-
ogy by perfusing the animal through the right
ventricle with PBS to remove all blood. Lungs
were then inflated to constant pressure (20
cm water) with Streck Tissue fixative (Streck
Labs) instilled through a tracheostomy tube.
Lung sections (5 mM) of WT or KRR mice
either Ova/Ova-treated ([C±F], respectively)
or Alum/Ova-treated (A and B) were mounted
on slides and stained with Giemsa or hema-
toxylin-eosin (H and E) according to estab-
lished procedures. WT Ova/Ova-treated mice
had impressive peribronchiolar and perivas-
cular eosinophilic inflammation (C and D). The
cells with a pink cytoplasmic stain are eosino-
phils. KRR mice displayed a significant re-
duction in eosinophilic inflammation (E and
F). Magnifications: (A), (C), and (E), 103; (B),
(D), and (F), 403.
(Lower panel) Quantitation of eosinophils in
the airways of WT and KRR mice. Eosinophils
were quantitated in tissue sections using an
eosinophil tissue index, which is the number
of eosinophils per square millimeter of bron-
chovascular area. The significance of differ-
ence between the two groups was analyzed
using Student's unpaired t test. Differences
in means were considered significant if P ,
0.05. *P , 0.02 compared with eosinophil
numbers present in the airways of WT mice.
Results shown are representative of three in-
dependent experiments.
the Th2 cells was likely due to incomplete inhibition of lower panel). The lungs of animals sham sensitized with
alum only and challenged with Ova (Figures 4A and 4B)endogenous wild-type GATA-3 activity by KRR. Since
the affinity of KRR for GATA doublets is considerably were totally devoid of any inflammation.
lower than that of the wild-type protein, complete inhibi-
tion of wild-type protein activity can be expected to Inhibition of Mucus Production in the Lungs
of KRR Micerequire sufficiently high levels of mutant protein expres-
sion. For example, a 10-fold excess of dominant-nega- A typical feature of asthma pathophysiology is mucus
overproduction in the airway epithelium. This feature oftive NF-ATc is reportedly required to achieve z90%
inhibition of wild-type NF-ATc activity (Northrop et al., human asthma is also mimicked in murine models of
asthma/allergic inflammation (Grunig et al., 1998; Wills-1994; Ranger et al., 1998). However, the precise mecha-
nism by which KRR interferes with wild-type activity, Karp et al., 1998; Cohn et al., 1999a). As shown in Figure
5, compared to sham-immunized animals (Figure 5A),whether as monomers, homodimers, or heterodimers
with the wild-type or other interacting proteins, is pres- there was an impressive increase in mucus production
in the airway epithelium of nontransgenic mice (Figureently unknown. Collectively, these results demonstrate
that the decrease in cytokine production by the T cells 5B). In contrast, mucus production was only marginally
increased in the lungs of the KRR mice (Figure 5C).isolated from the KRR mice was not due to a defect in
T cell priming.
Reduction of Ova-Specific IgE Levels in the Sera
of KRR MiceReduced Eosinophil Accumulation in the Lungs
of KRR Mice A key effector function of IL-4 is class switching of Ig
molecules to IgE. Since IL-4 was not consistently detect-We next examined the lungs of the antigen-challenged
mice histologically to determine the consequence of low able at high levels in the BALF of the antigen-challenged
wild-type or KRR animals, we assessed the effect ofTh2 cytokine gene expression in the airways. As shown
in Figures 4C and 4D, nontrangenic mice displayed a inhibition of GATA-3 activity on Ova-specific IgE produc-
tion. Measurement of Ova-specific IgE in the sera de-prominent eosinophilic inflammatory response in the
bronchovascular bundles. The KRR mice, on the other rived from the animals showed z10-fold more IgE levels
in the control mice compared to that in the KRR micehand, had sparse eosinophilic inflammation in their air-
ways upon antigen challenge (Figures 5E and 5F). In (Figure 6).
some KRR mice, a few patchy areas of a low degree
of inflammation were noted in which eosinophils were KRR Has Mutant Activity on Th2 Cytokine Production
but Wild-Type Effects on IFNg Productionbarely detectable (Figure 4E). There were 30- to 50-fold
fewer eosinophils/mm2 in the lung parenchyma of the We examined the effect of KRR on cytokine production
in unskewed activated CD41 T cell cultures. As shownKRR mice compared to that in the controls (Figure 4,
Immunity
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Figure 5. Inhibition of Mucus Production in
the Bronchial Epithelium of Antigen-Chal-
lenged KRR Mice
Lung sections (5 mM) were mounted on slides
and stained with periodic acid-Schiff base
(PAS), which stains mucus. Compared to the
sham-sensitized controls (A), the WT mice
challenged with Ova (B) show increased mu-
cus production in the goblet cells. Note the
reduced mucus staining in the bronchial epi-
thelium of the Ova-challenged KRR mice (C).
in Figure 7, KRR inhibited production of all the Th2 cyto- alone in vivo would be sufficient to inhibit the patho-
physiology of asthma. The following reasons persuadedkines similar to its effects in Th2-skewed populations.
Although KRR behaved as a dominant-negative mutant us to undertake this study. (1) The transcription fac-
tors c-Maf (Ho et al., 1996, 1998) (also Th2-specific) andin regards to Th2 cytokine production, its effect on IFNg
production was similar to that of the wild-type protein NF-ATc (Ranger et al., 1998; Yoshida et al., 1998) have
been shown to be critical for IL-4 gene expression. How-in that it inhibited IFNg production. This was also evident
in Th1-skewed cultures as was observed by Ouyang et ever, there was no evidence that either of these tran-
scription factors was important for IL-5 or IL-13 geneal. (1998). This suggests that the mechanism by which
GATA-3 promotes Th2 gene expression is different from expression in effector T cells. Indeed, in recent studies,
c-Maf2/2 animals lacked IL-4 production (Kim et al.,that involved in inhibition of IFNg gene expression re-
quiring distinct regions of the protein. 1999). However, exogenously supplied IL-4 supported
both IL-5 and IL-13 production in c-Maf-deficient CD41
T cells (Kim et al., 1999). (2) It has been unclear fromDiscussion
already published work whether GATA-3 is a key regula-
tor of IL-4, IL-5, and IL-13 gene expression. For example,Airway inflammation in asthma and allergic diseases is
a complex phenomenon driven predominantly by Th2- contrary to previous reports (Zheng and Flavell, 1997),
we and others have shown that GATA-3 expressiontype cells. Studies in both humans and mice show that
Th2 cell±derived cytokines are critical regulators of alone is sufficient for optimal IL-5 but not IL-4 gene
expression in a non-Th2 environment (Ouyang et al.,asthma pathogenesis. An understanding of the molecu-
lar mechanisms that regulate Th2 cytokine production 1998; Ranganath et al., 1998; Zhang et al., 1998). Also,
the transgenic mice data of Zheng and Flavell showedin vivo is of critical importance for the development of
minimal effects of GATA-3 on IL-5 and IL-13 gene ex-novel therapies for asthma and allergic diseases. We
pression (Zheng and Flavell, 1997). (3) Studies of micepreviously showed that the transcription factor GATA-3 is
lacking NF-kB showed differential control of IL-4 andexpressed in Th2 but not Th1 cells and plays a critical
IL-5 gene expression; NF-kB-deficienct mice displayedrole in IL-5 gene expression (Zhang et al., 1997). In this
a more pronouced defect in IL-5 gene expression (Yangstudy we asked whether inhibition of GATA-3 activity
et al., 1998). (4) There was limited information on regula-
tion of IL-13 gene expression which has been shown
to be a critical regulator of asthma pathogenesis. (5)
Recently, increased GATA-3 expression was documented
in the lungs of asthmatic subjects correlating with IL-5
mRNA expression and AHR (Nakamura et al., 1999).
The data presented here show that GATA-3 plays an
important role in the expression of all three cytokine
genes, IL-4, IL-5, and IL-13, and plays a critical regula-
tory role in promoting eosinophilia in vivo. Inhibition of
GATA-3 activity causes a severe blunting of Th2 effects
both locally in the lung (eosinphil influx, mucus produc-
tion) as well as systemically (IgE production).
GATA-3 belongs to the GATA family of transcription
that bind to the WGATAR (W 5 A/T; R 5 A/G) DNA
sequence through a highly conserved C4 zinc finger
domain (Orkin, 1992). GATA-3 is expressed primarily in
T lymphocytes and in the embryonic brain (George et
Figure 6. Reduction of Ova-Specific IgE in the Sera of OVA-Chal-
al., 1994). Targeted disruption of the GATA-3 gene inlenged KRR Mice
mice results in embryonic death on day 12, with a failure
Before performing BAL, sera were obtained from anesthetized mice.
of fetal hematopoiesis and defects in the central nervousSerum IgE concentrations were measured by ELISA. *P , 0.01 com-
system (Pandolfi et al., 1995). GATA-3 was shown to bepared to IgE in controls. Shown is a representative experiment of
two, with three to five animals per group in each experiment. an essential component in the earliest steps of T cell
GATA-3 Is Critical for Asthma Pathogenesis
479
Figure 7. KRR Inhibits IFNg Production
Splenic CD41 T cells (cells were pooled from
spleens of three mice in each group) were
isolated from transgenic mice (line 4) and
nontransgenic littermates and stimulated
with anti-CD3 and anti-CD28 antibodies un-
der neutral or Th1-skewing conditions. After
5 days in culture, cells were restimulated, and
after 72 hr culture supernatants were har-
vested for ELISA. Shown is a representative
experiment of two.
development in the thymus using antisense oligonucleo- activates the IL-5 promoter, GATA-3 may directly or
indirectly control the expression of IL-4 and IL-13.tides for GATA-3 in fetal thymus organ cultures (Hattori
et al., 1996) and by using GATA-32/2/RAG-22/2 chimeric Several studies show the importance of the Th2 cyto-
kines IL-4, IL-5, and IL-13 in the development of eosino-mice (Ting et al., 1996). Thus, GATA-3 is not a function-
ally redundant GATA-family protein in that it is a critical philic inflammation and AHR. In initial studies, IL-42/2
animals displayed reduced Th2 responses including air-regulator of both early T cell development and Th2 cyto-
kine gene expression in vivo. way eosinophilia and AHR in a model of allergic inflam-
mation (Kopf et al., 1993; Brusselle et al., 1995; CorryThe GATA-3 mutant KRR was shown to have dominant
negative effects on the activation of minimal TCR a and et al., 1996). However, adoptive transfer of IL-42/2 CD41
T cells to IL-42/2 (or wild-type) recipient mice resultedb enhancers in Jurkat cells, which have modest endoge-
nous levels of wild-type GATA-3 (Smith et al., 1995). in AHR and mucus production (Cohn et al., 1998). IL-
13, which also binds to the IL-4Ra subunit and thus hasHowever, recently, both wild-type and KRR were shown
to support low-level IL-4 expression in Th1 cells (Ouyang overlapping functions with IL-4, was also shown to be
important for the development of Th2 cells in vivo, al-et al., 1998). Activation of IL-4 gene expression in Th1
cells probably involves mechanisms that are distinct though unlike IL-4, a direct role for IL-13 in Th2 differenti-
ation has yet to be demonstrated (McKenzie et al., 1998).from those operative in Th2 cells, since even the wild-
type protein is incapable of supporting optimal expres- To sort out the specific functions of IL-4 and IL-13 in
the generation of allergic inflammation, Th2 cells weresion of the gene in Th1 cells. Either the low-level IL-4
expression in Th1 cells is mediated through binding of transferred into IL-4Ra2/2 mice (Cohn et al., 1999a).
When these cells were activated in the respiratory tract,GATA-3 to single GATA elements, to which both the
wild-type and mutant protein bind with equal affinity, or no eosinophilia or mucus production was detected
(Cohn et al., 1999a). When viewed in combination, theseit may be due to cooperation with proteins with which
GATA-3 does not normally cooperate in Th2 cells. Al- results suggested that blockade of both IL-4 and IL-13
is critical for the reduction of the inflammatory pathologythough the binding of KRR to single GATA elements
is indistinguishable from the binding of the wild-type in asthma. In other studies, use of a specific inhibitor
of IL-13 abolished mucus production and AHR (Grunigprotein (Smith et al., 1995), its binding to a GATA doublet
is weak (Figure 1). Our studies have shown the impor- et al., 1998; Wills-Karp et al., 1998) but did not reduce
eosinophilia (Wills-Karp et al., 1998). All studies reportedtance of the GATA doublet in activation of the IL-5 pro-
moter; mutation of either element completely eliminates to date suggest a critical role for IL-5 in eosinophilia
(Coffman et al., 1989; Dent et al., 1990; Foster et al.,activation of the promoter in Th2 cells (Zhang et al.,
1998). Since the single GATA elements in the IL-4 pro- 1996; Kopf et al., 1996; Cohn et al., 1999a). When IL-52/2
cells were transferred into IL-52/2 recipients, no eosino-moter have little or no role in GATA-3 responsiveness
of this gene in Th2 cells, it is possible that GATA-3 philia was observed, although mucus production was
unaffected (Cohn et al., 1999a). Taken together, theseactivates the IL-4 and IL-13 genes through binding to
GATA doublets elsewhere in the genes. Interestingly, studies show that inhibition of all the key features of
asthmaÐairway eosinophilia, mucus production, andstudies of Ko and Engel show a preference for GATA
double sites for the binding of GATA proteins (Ko and AHRÐrequires inhibition of function of all three cyto-
kines. Our studies suggest that this can be achieved byEngel, 1993). Several regions around the IL-4/IL-13 locus
were shown to bind GATA-3, but the functional implica- inhibition of GATA-3 function.
While the reduction in eosinophilia, AHR, and mucustions of these interactions remain to be determined
(Ranganath et al., 1998). Thus, while GATA-3 directly production in IL-4/IL-13 (or Stat6)-deficient animals is
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used. For the GATA-3 probe, a 360 bp ClaI/BglI GATA-3 cDNAdue to the lack of direct effects of these cytokines, it
fragment was used that hybridized with a 700 bp fragment from themay also be a consequence of a shift to the development
transgene. The blots were washed twice for 15 min each at roomof Th1 cells in the absence of the Th2-driving cytokines
temperature in 63SSPE/0.2% SDS, then twice for 15 min each at
that cross-regulate Th1 responses. Indeed, IFNg pro- 558C in 0.23SSPE/1.0% SDS, dried, and subjected to autoradiogra-
duction by Th1 cells reduces both Th2-induced airway phy. The founders were crossed to BALB/c mice to establish
transgenic lines.inflammation and mucus production (Cohn et al., 1999b).
However, in the present study, expression of KRR did
RPAnot result in a shift to increased Th1 responses despite
For RPA, a 309 bp 32P-labeled antisense RNA specific for theinhibition of IL-4 and IL-13 production. This can be ex-
transgene was derived by T7 polymerase-mediated in vitro tran-plained by our results and by those of Ouyang et al.
scription (MaxiScript kit; Ambion) of a template derived by PCR
showing the ability of KRR, like the wild-type protein, using a primer derived from the GATA-3 cDNA and a second primer
to inhibit IFNg production in Th1 cells (Figure 7; Ouyang derived from hGH poly(A) sequences, which was tagged with a T
promoter sequence. The b-actin antisense RNA was derived usinget al., 1998). This suggests that distinct regions in the
a template that was obtained from Ambion. Total RNA (40 mg) fromGATA-3 protein are involved in the inhibition of IFNg
each mouse was used in RPA. Conditions for RPA were essentiallyproduction and activation of Th2 cytokine gene ex-
as described previously (Yang et al., 1998), except that only RNasepression.
T1 (20 U/ml) was used for digestion of RNA duplexes. After digestion
To date, no asthma therapy can selectively target Th2 with RNase T1, the protected RNA duplexes were purified by phenol/
lymphocyte-mediated inflammation in asthmatics. Cor- chloroform extraction and ethanol precipitation and analyzed by
electrophoresis on 5% polyacrylamide/8 M urea gels. The gels wereticosteroids, the mainstay of asthma therapy, cause
dried and subjected to autoradiography.general immunosuppression and prolonged use is asso-
ciated with multiple side effects. We have provided evi-
Transfectionsdence that inhibition of activity of a Th2-specific factor
Rested D10 cells were washed once in serum-free RPMI 1640 me-
blunts an asthma-like phenotype in an animal model. dium and resuspended in the same medium. The cells (5 3 106)
Since GATA-3 is not ubiquitous and is expressed pre- were first stimulated with the antigen conalbumin and mitomycin
dominantly in T cells in adults and furthermore is not C±treated and T cell±depleted APCs in complete medium containing
5 U/ml of IL-2 for 72 hr. The cells were incubated with 5 mg ofrequired for Th1 responses, inhibition of GATA-3 activity
reporter plasmid, 5 mg of vector alone or tet O/P KRR plasmid, andby using antisense RNA or pharmacological approaches
2 mg of CMV-b-galactosidase plasmid (a monitor for tranfectionwill have one clear advantage over current treatment
efficiency) with or without 2 mg of lck-rtTA construct for 10 min at
modalities for asthmaÐselectivity. Thus, our results es- room temperature, and electroporation was carried out using Gene
tablish GATA-3 as a potential therapeutic target for the Pulser (Bio-Rad) at 0.27 kV and 960 mFD. The cells were left on ice
treatment of asthma and allergy. for 10±30 min, diluted to 5 ml with fresh medium, and incubated at
378C. Cells were harvested for reporter gene assays as described
previously (Zhang et al., 1997, 1998).Experimental Procedures
Sensitization and Challenge of MiceGeneration of Transgenic Mice
Mice were sensitized and challenged essentially as described pre-The lck-rtTA expression vector was made by inserting a 1.0 kb
viously (Yang et al., 1998). Mice were sensitized with 10 mg of oval-EcoRI/BamHI rtTA fragment isolated from the plasmid 172±1 neo
bumin (OVA; Sigma Chemical) and 1 mg of alum (Resorptar; Intergen)(a gift from Drs. H. Bujard and M. Gossen) into the plasmid pTLC
intraperitoneally on days 0 and 5. Sham-immunized mice receivedcontaining the lck proximal promoter, hGH intronic, and polyadenyl-
alum alone. On day 12, mice were challenged by exposing to anation sequences and the CD2 LCR at the 39 end (a gift from Dr. R.
aerosol of 1% OVA in PBS twice for 1 hr each at an interval of 4 hr.Bravo). The purified recombinant plasmid was digested with SpeI,
BAL and lung histology were as described previously (Yang et al.,and the fragment containing the lck-rtTA-hGH minigene was purified
1998).and used for microinjection. The KRR mutation (amino acids KRR in
positions 304±306 changed to AAA) was introduced into the murine
Cell Proliferation AssaysGATA-3 cDNA by polymerase chain reaction (PCR) techniques. The
Mice were sensitized as above by intraperitoneal injections of OVAtet O/P-KRR expression vector was made by inserting the following
plus alum on days 0 and 5. Spleens were harvested on day 12 andfragments in pBluescript II (KS1) plasmid (Stratagene): a 0.49 kb
CD41 T cells were prepared by positive selection using monoclonalXhoI/ClaI fragment consisting of heptamerized tet operator se-
antibodies to CD4 coupled to magnetic beads (MACS Miltenyi) andquences linked to the CMV minimal promoter (isolated from pUHC-
a MACS separation column. Syngeneic T cell±depleted splenocytes13±3 [Gossen and Bujard, 1992; Gossen et al., 1995]) was inserted
were used as antigen-presenting cells (APCs), which were preparedinto pBluescript II (KS1) plasmid. A BamHI/NotI fragment containing
by depletion of CD4 and CD8 T cells using antibody-coupled mag-hGH poly(A) and intronic sequences was next inserted into the poly-
netic beads (MACS Miltenyi) and were treated with mitomycin C aslinker region of the plasmid. An EcoRI fragment containing the KRR
described previously (Cohn et al., 1997). CD41 T cells (5 3 105;cDNA was blunt ended with Klenow polymerase and inserted into
pooled from two mice in each group) together with 5 3 105 APCsthe EcoRV site of the plasmid, and the orientation was determined
were cultured with OVA (0.1±100 mg/ml) in Bruff's medium supple-by digestion with HindIII and further confirmed by sequencing. The
mented with 5% fetal calf serum (FCS). Cultures were incubatedtet O/P-KRR-hGH fragment was isolated by digestion of the plasmid
for 72 hr, supernatants were collected for cytokine analyses, andwith BssH2, purified, and used for microinjection. The two con-
cultures were pulsed with 1 mCi of [methyl-3H]thymidine/well. Afterstructs were coinjected into the pronuclei of C57BL/63SJL F2 zy-
incubation at 378C for 24 hr, triplicate wells were harvested ontogotes. Transgene positive animals were identified initially by PCR
glass filters and incorporated radioactivity was measured in a band confirmed by Southern blotting techniques. Tail DNA from the
counter. The background was subtracted from the results.animals was digested with BamHI and resolved by gel electrophore-
sis. Hybridization with the rtTA probe and the GATA-3 probe was
carried out by overnight incubation in a buffer containing 63SSPE, Cytokine Assays
For determination of cytokine expression under Th2-skewing condi-0.5% SDS, 50% formamide, 50 mg/ml salmon sperm DNA, and the
probe at 5 3 106 cpm/ml of the hybridization buffer. For the rtTA tions, mice were sensitized with Ova plus alum on days 0 and 5.
The spleens of the mice were harvested on day 12, and CD41 Tprobe, a 1 kb EcoRI/BamHI fragment of rtTA isolated from the plas-
mid 172±1 neo (Gossen and Bujard, 1992; Gossen et al., 1995) was cells were purified as described above. The cells were incubated
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under Th2-skewing conditions with dox (10 mg/ml), IL-4, antigen, and Bottomly, K. (1999a). Th2-induced airway mucus production
is dependent on IL-4Ra, but not on eosinophils. J. Immunol. 162,anti-IFNg antibodies, and T cell±depleted and mitomycin C±treated
6178±6183.APCs as described previously (Zhang et al., 1997). After 5 days,
cells were restimulated with antigen and APC and incubated for 72 Cohn, L., Homer, R.J., Niu, N., and Bottomly, K. (1999b). Th1 cells
hr. IL-2, IL-4, and IL-5 protein levels in culture supernatants and in and IFN-g regulate allergic airway inflammation and mucus produc-
BAL (also IFNg levels in BAL) were determined by ELISA. For cyto- tion. J. Exp. Med., in press.
kine evaluations under Th1-skewed or unskewed conditions, puri- Collins, P.D., Marleau, S., Griffiths-Johnson, D.A., Jose, P.J., and
fied CD41 T cells were stimulated with plate-bound anti-CD3 and Williams, T.J. (1995). Cooperation between interleukin-5 and the
anti-CD28 antibodies (each at 2 mg/ml) with either dox (10 mg/ml), chemokine eotaxin to induce eosinophil accumulation in vivo. J.
IL-2 (50 U/ml), IL-12 (7.5 ng/ml), and anti-IL-4 antibody or with dox Exp. Med. 182, 1169±1174.
and IL-2 only, respectively. After 5 days in culture, cells were restim-
Corry, D.B., Folfesson, H.G., Warnock, M.L., Erle, D.J., Matthay,ulated with the antibodies in the presence of dox and IL-2. Culture
M.A., Wiener-Kronish, J.P., and Locksley, R.M. (1996). Interleukin-4,supernatants were harvested after 72 hours for ELISA. The lower
but not interleukin-5 or eosinophils, is required in a murine model
limits of detection for the cytokines were: IL-4, 5 pg/ml; IL-5, 5 pg/
of acute airway hyperreactivity. J. Exp. Med. 183, 109±117.
ml; IFNg, 15 pg/ml (Endogen); and IL-13, 1.5 pg/ml (RandD).
de Monchy, J.G.R., Kaufmann, H.F., Venge, P., Koeter, G.H., Jansen,
H.M., Sluiter, H.J., and de Vries, K. (1985). Bronchoalveolar eosino-Ova-Specific IgE Assay
philia during allergen-induced late asthmatic reactions. Am. Rev.Ova-specific IgE was estimated in the sera of the antigen-challenged
Respir. Dis. 131, 373±376.mice. 96-well microtiter plates were coated with Ova (Sigma) (50
Dent, L.A., Strath, M., Mellor, A.L., and Sanderson, C.J. (1990). Eosin-mg/ml) in 0.1 M NaHCO3 at 48C overnight. Plates were washed 3X
ophilia in transgenic mice expressing interleukin 5. J. Exp. Med.with PBS-Tween (0.05%) between each of the following assay incu-
172, 1425±1431.bations: (1) blocking with 1% BSA in Borate saline (BSA-BS) for 1
hr at 378C, (2) serial dilutions of sera in 1% BSA-BS-0.05% Tween Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young,
for 2 hr at 378C, (3) biotin-labeled secondary rat anti-mouse antibody I.G. (1996). Interleukin-5 deficiency abolishes eosinophilia, airways
(anti-IgE [2379±04S; Biosource]) for 1 hr at 378C, (4) streptavidin- hyperreactivity and lung damage in mouse asthma model. J. Exp.
horseradish peroxidase for 30 min at 378C, and (5) TMB substrate Med. 183, 195±201.
solution (Dako Corp) and termination of peroxidase reaction with Frick, W.E., Sedgwick, J.B., and Busse, W.W. (1989). The appear-
6N HCl. Color development was read at 405 nm in an ELISA plate ance of hypodense eosinophils in antigen-dependent late phase
reader. Serum IgE concentrations were calculated by comparison asthma. Am. Rev. Respir. Dis. 139, 1401±1406.
to a standard: monoclonal anti-Ova mouse IgE (kindly provided by George, K.M., Leonard, M.W., Roth, M.E., Lieuw, K.H., Kioussis,
Dr. E. Gelfand). D., Grosveld, F., and Engel, J.D. (1994). Embryonic expression and
cloning of the murine GATA-3 gene. Development 120, 2673±2686.
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